Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)- Insider Own46.10% Shs Outstand33.49M Perf Week8.07%
Market Cap668.13M Forward P/E- EPS next Y-2.90 Insider Trans16.62% Shs Float18.05M Perf Month25.47%
Income-96.02M PEG- EPS next Q-0.66 Inst Own41.48% Short Float8.92% Perf Quarter0.35%
Sales0.00M P/S- EPS this Y90.21% Inst Trans- Short Ratio9.54 Perf Half Y-
Book/sh9.49 P/B2.10 EPS next Y8.62% ROA- Short Interest1.61M Perf Year-
Cash/sh9.48 P/C2.11 EPS next 5Y- ROE- 52W Range14.35 - 25.95 Perf YTD-0.25%
Dividend Est.- P/FCF- EPS past 5Y- ROI-30.21% 52W High-23.12% Beta-
Dividend TTM- Quick Ratio32.82 Sales past 5Y0.00% Gross Margin- 52W Low39.02% ATR (14)1.07
Dividend Ex-Date- Current Ratio32.82 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)68.80 Volatility5.13% 6.28%
Employees40 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price30.20
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-66.77% Payout- Rel Volume0.24 Prev Close19.58
Sales Surprise- EPS Surprise35.02% Sales Q/Q- EarningsMay 08 BMO Avg Volume168.70K Price19.95
SMA2014.36% SMA5013.10% SMA2005.63% Trades Volume41,194 Change1.89%
Date Action Analyst Rating Change Price Target Change
Apr-30-24Initiated H.C. Wainwright Buy $25
Feb-20-24Initiated Jefferies Buy $35
Feb-20-24Initiated Goldman Buy $27
Feb-20-24Initiated Citigroup Buy $30
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HILLHOUSE INVESTMENT MANAGEMEN10% OwnerJan 30 '24Buy18.00555,5559,999,9904,484,672Feb 01 04:47 PM
HEALY JAMESDirectorJan 30 '24Buy18.00444,4447,999,9921,696,752Jan 31 04:10 PM
GORDON CARL LDirectorJan 30 '24Buy18.00444,4447,999,9921,513,664Jan 31 04:11 PM
ORBIMED ADVISORS LLCDirectorJan 30 '24Buy18.00444,4447,999,9921,513,664Jan 31 04:12 PM